.png)
German (DE) 
English (US) 
Spanish (ES) 
French (FR) 
Hindi (IN) 
Italian (IT) 
Russian (RU) TipRanks
Wed, May 14, 2025, 3:00 AM 7 min read
In This Article:
Every investor likes to find a clear market signal, indicating the right stock to buy – and there are few signals clearer than the insider purchases. Now, these are not criminal moves; the insiders we’re talking about are corporate officers, from the C-suites and the Boards of Directors, who have a responsibility for delivering profits and returns while answering to their investors, and whose positions give them a clear view of the inner workings and prospects of their companies.
-
Quickly and easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
-
Receive undervalued, market resilient stocks straight to you inbox with TipRanks' Smart Value Newsletter
That’s a heady combination, but what it means is simple. These insiders don’t buy their own firms’ stock shares lightly, and when they start pouring millions of dollars into them, the reason can only be that they believe the stock will soon appreciate.
So let’s start taking a look at some stocks that the insiders like. These are shares that have recently seen million-dollar purchases from their inside owners; according to the TipRanks data platform, both have Strong Buy consensus ratings from the Street’s analysts. A look into the details may show us why you should follow the insiders, and buy into these as well.
MiMedx Group (MDXG)
We’ll start in the medical research field, with MiMedx Group. This biotech research company is a pioneer in the field of wound healing. MiMedx uses placental biologics, particularly placental and amniotic tissue, to develop regenerative treatments for chronic wounds, focusing on wound care, burn care, and post-surgical closures. The company aims to become the medical world’s leading provider of advanced healing solutions, with a direct and positive impact on patients’ quality of life.
MiMedx’s research focuses on developing new lines of allograft products that are based on the healing and regenerative properties of human placental and amniotic tissues. These are the tissues that support fetal development during pregnancy, and they are known to promote growth and development of other human tissues.
Following this approach, MiMedx has developed three product lines. The first is EPIFIX, which uses an allograft of dehydrated amnion/chorion membrane to provide a protective barrier on a wound, with a biocompatible extracellular matrix (ECM) to aid in the development of granulation tissue. The second product line, EPICORD, is a dehydrated human umbilical cord allograft, also designed to provide a protective environment that promotes wound healing. EPICORD’s action is based on an ECM that combines hyaluronic acid and collagen. Finally, EPIEFFECT uses a lyophilized human placental-based allograft membrane to form a barrier that gives acute and chronic wounds a protective environment. EPIEFFECT includes three layers, an amnion layer, an intermediate layer, and a chorion layer.
Comments